Mary E Moya-Mendez1, Lyndsay L Madden2, Kathryn W Ruckart2, Karen M Downes2, Jared F Cook3, Beverly M Snively4, Allison Brashear5, Ihtsham U Haq6. 1. Department of Neurology Duke University School of Medicine Durham, North Carolina, United States. 2. Department of Otolaryngology-Head and Neck Surgery, Wake Forest School of Medicine Winston-Salem, NC, United States. 3. Department of Psychology, Wake Forest School of Medicine Winston-Salem, NC, United States. 4. Department of Biostatistics and Data Science, Wake Forest School of Medicine Winston-Salem, NC, United States. 5. Department of Neurology, University of California at Davis, Sacramento, CA, United States. 6. Department of Neurology, Wake Forest School of Medicine Winston-Salem, NC, United States. Electronic address: ihaq@med.miami.edu.
Abstract
INTRODUCTION: Bulbar symptoms are frequent in patients with rapid-onset dystonia-parkinsonism (RDP). RDP is caused by ATP1A3 mutations, with onset typically within 30 days of stressor exposure. Most patients have impairments in speech (dysarthria) and voice (dysphonia). These have not been quantified. We aimed to formally characterize these in RDP subjects as compared to mutation negative family controls. METHODS: We analyzed recordings in 32 RDP subjects (male = 21, female = 11) and 29 mutation negative controls (male = 15, female = 14). Three raters, blinded to mutation status, rated speech and vocal quality. Dysarthria was classified by subtype. Dysphonia was rated via the GRBAS (Grade, Roughness, Breathiness, Asthenia, Strain) scale. We used general neurological exams and the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) to assess dysarthria, dystonia, and speech/swallowing dysfunction. RESULTS: The presence of dysarthria was more frequent in RDP subjects compared to controls (72% vs. 17%, p < 0.0001). GRBAS voice ratings were worse in the RDP cohort across nearly all categories. Dysarthria in RDP was associated with concordant cranial nerve 9-11 dysfunction (54%, p = 0.048), speech/swallowing dysfunction (96%, p = 0.0003); and oral dystonia (88%, p = 0.001). CONCLUSIONS: Quantitative voice and speech analyses are important in assessing RDP. Subjects frequently experience dysarthria and dysphonia. Dystonia is not the exclusive voice abnormality present in this population. In our analysis, RDP subjects more frequently experienced bulbar symptoms than controls. GRBAS scores are useful in quantifying voice impairment, potentially allowing for better assessments of progression or treatment effects. Future directions include using task-specific diagnostic and perceptual voice evaluation tools to further assess laryngeal dystonia.
INTRODUCTION: Bulbar symptoms are frequent in patients with rapid-onset dystonia-parkinsonism (RDP). RDP is caused by ATP1A3 mutations, with onset typically within 30 days of stressor exposure. Most patients have impairments in speech (dysarthria) and voice (dysphonia). These have not been quantified. We aimed to formally characterize these in RDP subjects as compared to mutation negative family controls. METHODS: We analyzed recordings in 32 RDP subjects (male = 21, female = 11) and 29 mutation negative controls (male = 15, female = 14). Three raters, blinded to mutation status, rated speech and vocal quality. Dysarthria was classified by subtype. Dysphonia was rated via the GRBAS (Grade, Roughness, Breathiness, Asthenia, Strain) scale. We used general neurological exams and the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) to assess dysarthria, dystonia, and speech/swallowing dysfunction. RESULTS: The presence of dysarthria was more frequent in RDP subjects compared to controls (72% vs. 17%, p < 0.0001). GRBAS voice ratings were worse in the RDP cohort across nearly all categories. Dysarthria in RDP was associated with concordant cranial nerve 9-11 dysfunction (54%, p = 0.048), speech/swallowing dysfunction (96%, p = 0.0003); and oral dystonia (88%, p = 0.001). CONCLUSIONS: Quantitative voice and speech analyses are important in assessing RDP. Subjects frequently experience dysarthria and dysphonia. Dystonia is not the exclusive voice abnormality present in this population. In our analysis, RDP subjects more frequently experienced bulbar symptoms than controls. GRBAS scores are useful in quantifying voice impairment, potentially allowing for better assessments of progression or treatment effects. Future directions include using task-specific diagnostic and perceptual voice evaluation tools to further assess laryngeal dystonia.
Authors: P L Kramer; M Mineta; C Klein; K Schilling; D de Leon; M R Farlow; X O Breakefield; S B Bressman; W B Dobyns; L J Ozelius; A Brashear Journal: Ann Neurol Date: 1999-08 Impact factor: 10.422
Authors: Ihtsham U Haq; Beverly M Snively; Kathleen J Sweadner; Cynthia K Suerken; Jared F Cook; Laurie J Ozelius; Charlotte Miller; William V McCall; Christopher T Whitlow; Allison Brashear Journal: Mov Disord Date: 2019-07-30 Impact factor: 10.338
Authors: Rosa Burgos; Irene Bretón; Emanuele Cereda; Jean Claude Desport; Rainer Dziewas; Laurence Genton; Filomena Gomes; Pierre Jésus; Andreas Leischker; Maurizio Muscaritoli; Kalliopi-Anna Poulia; Jean Charles Preiser; Marjolein Van der Marck; Rainer Wirth; Pierre Singer; Stephan C Bischoff Journal: Clin Nutr Date: 2017-09-22 Impact factor: 7.324
Authors: Peter C Belafsky; Debbie A Mouadeb; Catherine J Rees; Jan C Pryor; Gregory N Postma; Jacqueline Allen; Rebecca J Leonard Journal: Ann Otol Rhinol Laryngol Date: 2008-12 Impact factor: 1.547
Authors: W B Dobyns; L J Ozelius; P L Kramer; A Brashear; M R Farlow; T R Perry; L E Walsh; E J Kasarskis; I J Butler; X O Breakefield Journal: Neurology Date: 1993-12 Impact factor: 9.910